WASHINGTON (dpa-AFX) - Gold prices fell on Thursday on a firmer U.S. dollar as investors awaited monetary policy decision from the European Central Bank for more clarity about its stimulus plans
- Consumer staples: Salmar SALM.NO -5.1% (placement completion).
-
-
-
Healthcare: Clinigen CLIN.UK -25.8% (trading update), Oasmia Pharma OASM.SE +4.0% (research update), Smith & Nephew SN.UK +3.3% (analyst action).
- Industrials: Leclanche LECN.CH +1.4% (results), Aker Solutions AKSO.NO.+1.2% (agreement with Petrobras), Heidelberger Drukmaschinen HDD.DE -13.2% (results).
Speakers
-
BOE s Haldane (chief economist, QE dissenter) noted that the domestic economy was going gangbusters at this time and needed to begin turning off the monetary policy tap. If pay and costs were picking up then inflation was not very far behind.
-
-
Sweden Central Bank (Riksbank) Gov Ingves stated that he expected inflation to fall in the short-term and then gradually rise back towards the 2% target. Reasonable to believe that inflation sped up after July. He saw big risks in withdrawing policy measures too early.